Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in Trial of OncoSec's TAVO™, Epacadostat and KEYTRUDA® Combo

americanpharmaceuticalreviewMay 24, 2019

Tag: First , OncoSec's TAVO™ , trial

PharmaSources Customer Service